期刊文献+

DSPE-PEG-胆酸修饰水飞蓟宾脂质体对CCl_4致急性肝损伤小鼠的保护作用研究 被引量:1

Protective effect of DSPE-PEG-cholic acid modified silybin liposome on CCl_4-induced acute hepatic injury in mice
原文传递
导出
摘要 目的:研究DSPE-PEG-胆酸修饰水飞蓟宾脂质体对四氯化碳(CCl4)所致小鼠急性肝损伤的保护作用。方法:将48只雄性ICR种小鼠随机分成6组:正常对照组、CCl_4肝损伤模型组、水飞蓟宾胶囊剂组、水飞蓟宾修饰脂质体低、中、高剂量组。采用腹腔注射CCl4致小鼠急性肝损伤模型,测定小鼠血清谷丙转氨酶(alanine aminotransferase,ALT)、谷草转氨酶(aspartate aminotransferase,AST);测定肝脏丙二醛(malondialdehyde,MDA)含量,谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-Px)含量和超氧化物歧化酶(superoxide dismutase,SOD)活力,计算肝指数,并观察肝组织病理学变化。结果:与CCl_4模型组比较,各治疗组小鼠肝脏指数、血清ALT和AST活性不同程度降低(P<0.05);肝组织匀浆中MDA,GSH-Px,SOD活力不同程度升高(P<0.05);病理切片表明小鼠肝损伤不同程度减轻,而且脂质体组比胶囊剂组有较好改善。结论:DSPE-PEG-胆酸修饰水飞蓟宾脂质体对CCl_4所致小鼠急性肝损伤有显著的保护作用,且高于水飞蓟宾胶囊剂组。 Objective: To determine the protective effect of DSPE-PEG-cholic acid modified silybin liposome on CCl4-induced acute hepatic injury in mice. Methods: 48 male ICR mice were randomly divided into 6groups: normal control group,CCl4 induced liver damage model,silybin capsule as positive group,modified liposome with low,medium and high dose group. Establishing acute liver injury in mice model by intraperitoneal injection of CCl4,alanine aminotransferase( ALT) and aspartate aminotransferase( AST) in plasma,and malondialdehyde( MDA),glutathione peroxidase( GSH-Px) and superoxide dismutase( SOD) activity in the liver were determined; the liver index were calculated; hepatic histopathological changes were observed. Results:Compared with CCl4 model group,the liver index,and ALT and AST activities in serum significantly decreased( P〈0. 05); MDA,GSH-Px and SOD activity in the liver homogenate significantly increased( P〈0. 05) after the silybin liposome treatment. Histopathologic examination showed that silybin liposome alleviated the liver injury,and high dose( 5 mg·kg^-1) was more effective. Conclusion: DSPE-PEG-cholic acid modified silybin liposome has significant protective effect on acute liver injury induced by CCl4 in mice,and is more potent than silybin capsule.
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第21期2495-2499,共5页 Chinese Journal of New Drugs
基金 北京市自然科学基金资助项目(7162131)
关键词 水飞蓟宾 DSPE-PEG-胆酸 脂质体 保肝 CCL4 急性肝损伤 silybin DSPE-PEG-cholic acid liposomes liver-protective effect CCl4 acute hepatic injury
  • 相关文献

参考文献10

  • 1KAUR M,AGARWAL R. Silymarin and epithelial cancer che-moprevention: How close we are to beside? [J]. Toxicol ApplPharmacol,2007,224( 3) : 350 - 359.
  • 2KREN V,WALTEROVA D. Silybin and silymarin-new effectsand applications[J]. Biomed Pap Med Fac Univ Palacky Olo-mouc Czech Repub,2005,149( 1) : 29 - 41.
  • 3BASIGLIO CL,SANCHEZ POZZI EJ,MOTTINO AD,et al.Differential effects of silymarin and its active component silibininon plasma membrane stability and hepatocellularlysis[J]. ChemBiol Interact,2009,179( 2 - 3) : 297 - 303.
  • 4WU W,WANG Y,QUE L. Enhanced bioavailability of silyma-rin by self-microemulsifying drug delivery system [J]. Eur JPharm Biopharm,2006,63( 3) : 288 - 294.
  • 5ANANTHANARAYANAN M,BALASUBRAMANIAN N,MAK-ISHIMA M,et al. Human bile salt export pump promoter is trans-activated by the farnesoid X receptor/ bile acid receptor[J]. J Bi-ol Chem,2001,276( 31) : 28857 - 28865.
  • 6SWAAN PW,SZOKA FC,QIE S. Use of the intestinal and he-patic bile acid transporters for drug delivery[J]. Adv Drug DelivRev,1996,20 ( 1) : 59 - 82.
  • 7KAGEDAHL M,SWAAN PW,REDEMANN CT,et al. Use ofthe intestinal bile acid transporter for the uptake of cholic acidconjugates with HIV-1 protease inhibitory activity[J]. PharmRes,1997,14( 2) : 176 - 180.
  • 8QIAN S,WU JB,WU XC,et al. Synthesis and characterizationof new liver targeting 5-fluorouracil-cholic acid conjugates[J].Arch Pharm ( Weinheim) ,2009,342( 9) : 513 - 520.
  • 9赵文玺,金梅花,李天,王玉娇,全吉淑.草苁蓉水萃取物对四氯化碳致肝损伤小鼠肝脏氧化应激的干预作用[J].中国中药杂志,2013,38(6):875-878. 被引量:39
  • 10QUAN J,YIN X,XU H. Boschniakia rossica prevents the car-bon tetrachloride-induced hepatotoxicity in rats[J]. Exp ToxicolPathol,2011,63( 1 - 2) : 53 - 59.

二级参考文献12

共引文献38

同被引文献19

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部